Abstract
SummaryInterim findings are reported from a planned 3-year study of the psychological, hormonal and plasma tryptophan changes occurring in women following hysterectomy and who have been treated with either piperazine oestrone sulphate (1.5 mg b.d.) or placebo for 6 months or longer. In patients treated with piperazine oestrone sulphate, there was a highly significant reduction in depressive symptoms, and a significant increase in total plasma tryptophan. In contrast to the hormone-treated patients, the placebo-treated group showed no such changes, but a significant increase in plasma luteinizing hormone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
